News & Views
TC BioPharm Completes Clinical Manufacturing Facility
Sep 27 2013
With additional seed funds of £250k TC BioPharm (TCB) has been able to complete construction of its new clinical manufacturing facility at Maxim Park, Glasgow, in a record time of 12 weeks and 2 days, bringing it one step closer to treating cancer patients during 2015.
Initially backed by MEDINET and Scottish investors, the additional funding from the Scottish Investment Bank enabled TCB to build its cleanroom facilities and offices alongside the quality control suites and development laboratories Up to 3,500 sq ft (325m2) of the total 5,000 sq ft (465m2) footfall will support manufacture of clinical grade product.
TCB is developing a technology to use a patient’s own immune cells to target cancer and plans to treat its first cohort of patients during 2015, working alongside established cancer clinics in Glasgow, Southampton and Birmingham.
Its next step is to get an IMP (Investigational Medicinal Product) licence from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) before clinical product can be made. Stating the importance of this licence Angela Scott, TC BioPharm’s operations director commented: “The team at TC BioPharm has done an amazing job building and commissioning our GMP cleanrooms here in Glasgow. All our efforts are now focussed on meeting UK regulations prior to MHRA inspection of the facility in November.”
TCB’s executive chairman Dr Artin Moussavi said: “The team is rapidly advancing towards launch of a novel cell therapy for treatment of cancer patients in Europe, and opening of our clinical manufacturing facility marks an important milestone along this journey. The initial target indication is melanoma, a significant unmet medical need. We believe our gamma delta T cell platform has an excellent chance of providing safe and effective therapy for these patients.”
Digital Edition
Lab Asia 31.2 April 2024
April 2024
In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...
View all digital editions
Events
Apr 28 2024 Montreal, Quebec, Canada
May 05 2024 Seville, Spain
InformEx Zone at CPhl North America
May 07 2024 Pennsylvania, PA, USA
May 14 2024 Oklahoma City, OK, USA
May 15 2024 Birmingham, UK